Free to read · nothing for sale · no ads, no sponsors · funded by donation

Open Source Apothecary At Home

Open Source Apothecary At Home / Urinary and reproductive

Menopause: hot flushes and the honest evidence

Black cohosh, red clover and soy isoflavones all have trials. All of them are modest, and HRT is more effective.

remedy

Vasomotor symptoms — hot flushes and night sweats — are the main menopausal symptom, and the honest hierarchy is that hormone therapy is substantially more effective than any plant preparation.

Hormone replacement therapy reduces hot flushes by around 75% in trials and is the most effective treatment. The risk-benefit discussion is genuinely nuanced and has been distorted in both directions since the Women's Health Initiative; the current position is that for most women under 60 or within 10 years of menopause, the benefits generally outweigh the risks, and it is a decision to make with a clinician. This handbook cannot make it, and it should not pretend a herb is equivalent.

Black cohosh has multiple randomised trials with inconsistent results; pooled analyses generally find a small effect over placebo, and several well-designed trials have found none. There are rare reports of liver injury. It may act centrally rather than through oestrogen, which is why the older "phytoestrogen" framing is probably wrong.

Soy isoflavones — the trials are heterogeneous, with a modest effect in some pooled analyses and none in others. The effect, where present, is small and much less than hormone therapy.

Red clover isoflavones — similar picture; small and inconsistent effects.

St John's wort has small trials for menopausal symptoms, with a modest effect. It interacts with a very long list of drugs, including tamoxifen, which is relevant in this population.

Vaginal symptoms — dryness, pain with sex, recurrent urinary infection — are not treated by any of the above and are treated effectively by topical vaginal oestrogen, which is safe in almost everyone and not equivalent to systemic hormone therapy. This is an underused and highly effective treatment.

Hot flush triggers that can be managed. Alcohol, caffeine, spicy food, hot drinks, and a hot environment. Layering clothing. Weight loss reduces symptoms. Cognitive behavioural therapy has randomised evidence for hot flushes and for sleep.

The frame that matters. A woman with severe vasomotor symptoms and a poor night's sleep for months is suffering a treatable condition. Offering her black cohosh is offering a coin-flip when there is a treatment with a 75% effect size. Name both.

What the studies found

Meta-Analysis2025PeerJ

Effects of soy isoflavones on menopausal symptoms in perimenopausal women: a systematic review and meta-analysis.

More trials should be conducted in the future to validate our findings.
PubMed 40718787 ↗
Meta-Analysis2025European journal of obstetrics, gynecology, and reproductive biology

Pharmacological Treatments for Menopausal Vasomotor Symptoms: A Systematic Review and Bayesian Network Meta-Analysis of Efficacy and Safety.

Conjugated estrogens and drospirenone with estradiol are the most effective options for reducing VMS frequency and severity, and Fezolinetant and Elinzanetant showed moderate efficacy, with overall similar safety across treatments.
PubMed 40592206 ↗
Meta-Analysis2024European journal of obstetrics, gynecology, and reproductive biology

Effectiveness and safety of fezolinetant in alleviating vasomotor symptoms linked to Menopause.: A systematic review and Meta-Analysis.

Fezolinetant has demonstrated efficacy in reducing the frequency and severity of VMS in postmenopausal women, leading to an improvement in their quality of life.
PubMed 38640780 ↗
Meta-Analysis2024Climacteric : the journal of the International Menopause Society

Fezolinetant for the treatment of vasomotor symptoms associated with menopause: a meta-analysis.

These findings support the efficacy and safety of fezolinetant for the treatment of VMS related to menopause.
PubMed 38619017 ↗
Meta-Analysis2024Journal of pineal research

Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response Meta-Analysis.

Our results suggest that advancing the timing of administration (3 h before the desired bedtime) and increasing the administered dose (4 mg/day), as compared to the exogenous melatonin schedule most used in clinical practice (2 mg 30 min before the desired bedtime), might optimize the efficacy of exogenous melatonin in promoting sleep.
PubMed 38888087 ↗
Meta-Analysis2023Menopause (New York, N.Y.)

Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis.

This study provides updated evidence regarding the potentially beneficial effects of black cohosh extracts for relieving menopausal symptoms in menopausal women.
PubMed 37192826 ↗

Preparation

Black cohosh

  • 20-40 mg daily of a standardised extract
  • Trials are inconsistent; the effect is small
  • Rare reports of liver injury. Stop if jaundice, dark urine or fatigue develops.
  • Not with a history of liver disease or breast cancer without oncology advice

Soy isoflavones

  • 40-80 mg of isoflavones daily; the effect is small and inconsistent
  • Food sources: soy beans, tofu, edamame, soy milk

Red clover isoflavones

  • 40-80 mg daily; similar picture

St John's wort

  • Small trials show a modest effect on menopausal symptoms
  • Interacts with many drugs, including tamoxifen and hormonal therapies. Check before use.
  • Photosensitising

Vaginal dryness and urinary symptoms

  • Topical vaginal oestrogen — the effective treatment, and safe in almost everyone. Underused.
  • A vaginal moisturiser for regular use and a lubricant for sex
  • None of the oral herbs above treat this

Sleep

  • CBT for insomnia has randomised evidence in menopause
  • Melatonin at low dose for a timing problem; not a hypnotic

What helps and is free

  • Identify triggers: alcohol, caffeine, spicy food, hot drinks, hot rooms
  • Layered clothing; a cool bedroom; a fan
  • Weight loss reduces hot flushes and other symptoms
  • Exercise; resistance training preserves bone and muscle
  • CBT has randomised evidence for hot flushes and sleep

The clinical conversation

  • Hormone therapy is more effective than anything on this page. For most women under 60 or within 10 years of menopause, the balance usually favours treatment, and it is a decision with a clinician.
  • Non-hormonal prescription options exist too (some SSRIs/SNRIs and gabapentin reduce flushes).
  • Discuss the bone and cardiovascular implications; menopause is a good time for baseline risk checks.

Cautions and interactions

When this is not a self-care problem — get help

Related

Sources

  1. Effects of soy isoflavones on menopausal symptoms in perimenopausal women: a systematic review and meta-analysis. PeerJ 2025; doi:10.1016/j.jnutbio.2021.108910 PubMed 40718787
  2. Pharmacological Treatments for Menopausal Vasomotor Symptoms: A Systematic Review and Bayesian Network Meta-Analysis of Efficacy and Safety. European journal of obstetrics, gynecology, and reproductive biology 2025; doi:10.1016/j.ejogrb.2025.114552 PubMed 40592206
  3. Effectiveness and safety of fezolinetant in alleviating vasomotor symptoms linked to Menopause.: A systematic review and Meta-Analysis. European journal of obstetrics, gynecology, and reproductive biology 2024; doi:10.1016/j.ejogrb.2024.04.017 PubMed 38640780
  4. Fezolinetant for the treatment of vasomotor symptoms associated with menopause: a meta-analysis. Climacteric : the journal of the International Menopause Society 2024; doi:10.1080/13697137.2024.2334083 PubMed 38619017
  5. Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response Meta-Analysis. Journal of pineal research 2024; doi:10.1111/jpi.12985 PubMed 38888087
  6. Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis. Menopause (New York, N.Y.) 2023; doi:10.1021/jf0606149 PubMed 37192826